Kennedy Van der Laan has advised Pirana, a widely used product for connecting and organizing pharmacometric modeling results as well as providing interfaces to a range of software tools used in pharmacometrics modeling, as Dutch counsel on its sale to Certara, the global leader in model-informed drug development, regulatory science, market access and real-world evidence solutions. Our team consisted of Meltem Koning-Gungormez, Joran Spauwen and Hanne van ‘t Klooster.
Please find the press release here.
Want to find out more about this deal? Or do you need legal services? Please contact Joran Spauwen.
